摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,1-bis(3-methyl-2-thienyl)but-1-en-4-yl methanesulfonate | 847233-13-0

中文名称
——
中文别名
——
英文名称
1,1-bis(3-methyl-2-thienyl)but-1-en-4-yl methanesulfonate
英文别名
4,4-bis-(3-methyl-2-thienyl)but-3-en-1-yl methanesulfonate;4,4-bis(3-methylthiophen-2-yl)but-3-en-1-yl methanesulfonate;1,1-bis (3-methyl-2-thienyl)-4-methyl-1-butene sulfonate;4,4-Bis(3-methylthiophen-2-yl)but-3-en-1-yl methanesulfonate;4,4-bis(3-methylthiophen-2-yl)but-3-enyl methanesulfonate
1,1-bis(3-methyl-2-thienyl)but-1-en-4-yl methanesulfonate化学式
CAS
847233-13-0
化学式
C15H18O3S3
mdl
——
分子量
342.504
InChiKey
BFHMSMJGYIQEHR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    128-130 °C(Solv: tetrahydrofuran (109-99-9); heptane (142-82-5))
  • 沸点:
    537.2±50.0 °C(Predicted)
  • 密度:
    1.274±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.3
  • 重原子数:
    21
  • 可旋转键数:
    6
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    108
  • 氢给体数:
    0
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1,1-bis(3-methyl-2-thienyl)but-1-en-4-yl methanesulfonate 在 C63H78IrNOP(2+)*C32H12BF24(1-)氢气potassium carbonate 、 potassium iodide 、 sodium hydroxide 作用下, 以 甲醇丙酮 为溶剂, 20.0~60.0 ℃ 、607.99 kPa 条件下, 反应 134.0h, 生成 噻加宾
    参考文献:
    名称:
    铱催化不饱和杂环酸的对映选择性加氢
    摘要:
    螺旋结合:一种高度对映选择性的不饱和杂环羧酸的加氢已经通过使用手性铱/ spirophosphino恶唑啉催化剂开发(参见方案; BAR ˚F - =四[3,5-双(三氟甲基)苯基]硼酸盐,的Boc =叔丁氧羰基) 。该反应提供了制备具有优异对映选择性的旋光杂环酸的有效方法。
    DOI:
    10.1002/anie.201301341
  • 作为产物:
    参考文献:
    名称:
    铱催化不饱和杂环酸的对映选择性加氢
    摘要:
    螺旋结合:一种高度对映选择性的不饱和杂环羧酸的加氢已经通过使用手性铱/ spirophosphino恶唑啉催化剂开发(参见方案; BAR ˚F - =四[3,5-双(三氟甲基)苯基]硼酸盐,的Boc =叔丁氧羰基) 。该反应提供了制备具有优异对映选择性的旋光杂环酸的有效方法。
    DOI:
    10.1002/anie.201301341
点击查看最新优质反应信息

文献信息

  • 盐酸噻加宾的制备与纯化方法
    申请人:赵学清
    公开号:CN103570703B
    公开(公告)日:2016-03-23
    本发明提供了盐酸噻加宾的制备与纯化方法,该方法为直接使用R-哌啶-3-甲酸乙酯·L-酒石酸盐(2)、或R-哌啶-3-甲酸乙酯作原料,在足量的碳酸钾存在下,与烃化剂1,1-二(3-甲基-2-噻吩基)-4-X-1-丁烯(1,X=Cl、Br、I、OTs、OMs)反应,所得噻加宾乙酯(3)的粗品,直接进行强碱水解,所得盐酸噻加宾粗品经两次的“在二氯甲烷-水系统中碱溶,再以盐酸成盐”的过程,可去除噻加宾乙酯粗品中所带入的各种杂质,获得高纯度的盐酸噻加宾(4)纯品。本发明缩短了工艺步骤,革除柱层析,简化了工艺程序,大幅减低成本,获得了高纯度的产品。
  • Enantioselective Synthesis of (R)-Tiagabine via Asymmetric Hydrogen Atom Transfer Protocol
    作者:Jie Jiang、Yong-Qiang Zhang、Longfei Li、Wanjiao Chen、Zhongyun Xu
    DOI:10.1055/a-2039-6180
    日期:——
    An enantioselective synthesis of tiagabine has been achieved utilizing an asymmetric hydrogen atom transfer protocol to construct its essential chiral tertiary carbon center. A cyclization reaction via double N-substitution is tactically orchestrated as the other key step to install the crucial alkaloid ring. Compared with the previous synthetic strategy, which used commercially available nicotinate
    利用不对称氢原子转移方案构建其必需的手性叔碳中心,实现了噻加宾的对映选择性合成。通过双 N-取代的环化反应被巧妙地安排为安装关键生物碱环的另一个关键步骤。与以往使用市售烟酸酯作为起始原料以确保合成路线短的合成策略相比,该策略使用易于修饰和易于获得的烷基取代丙烯酸酯作为起始原料,从而为类似物的简便合成提供了方案和 tiagabine 的衍生物用于进一步的生物学研究。
  • Selective inhibitors of GABA uptake: synthesis and molecular pharmacology of 4-N-methylamino-4,5,6,7-tetrahydrobenzo[d]isoxazol-3-ol analogues
    作者:Rasmus P. Clausen、Ejner K. Moltzen、Jens Perregaard、Sibylle M. Lenz、Connie Sanchez、Erik Falch、Bente Frølund、Tina Bolvig、Alan Sarup、Orla M. Larsson、Arne Schousboe、Povl Krogsgaard-Larsen
    DOI:10.1016/j.bmc.2004.10.029
    日期:2005.2
    A series of lipophilic diaromatic derivatives of the glia-selective GABA uptake inhibitor (R)-4-amino-4,5,6,7-tetrahydrobenzo[d]isoxazol-3-ol [(R)-exo-THPO, 4] were synthesized via reductive amination of 3-ethoxy-4,5,6,7-tetrahydrobenzo[d]isoxazol-4-one (9) or via N-alkylation of O-alkylatedracemic 4. The effects of the target compounds on GABA uptake mechanisms in vitro were measured using a rat brain synaptosomal preparation or primary cultures of mouse cortical neurons and glia cells (astrocytes), as well as HEK cells transfected with cloned mouse GABA transporter subtypes (GAT1-4). The activity against isoniazid-induced convulsions in mice after subcutaneous administration of the compounds was determined. All of the compounds were potent inhibitors of synaptosomal uptake the most potent compound being (RS)-4-[N-(1,1-diphenylbut-1-4-en-yl)amino]-4,5,6,7-tetrahydrobenzo[d]isoxazol-3-ol (17a, IC50 = 0.14 muM). The majority of the compounds showed a weak preference for glial, as compared to neuronal, GABA uptake. The highest degree of selectivity was 10-fold corresponding to the glia selectivity of (R)-N-methyl-exo-THPO (5). All derivatives showed a preference for the GAT1 transporter, as compared with GAT2-4, with the exception of (RS)-4-[N-[1,1-bis(3-methyl-2-thienyl)but-1-en-4-yl]-N-methylamino]-4,5,6,7-tetrahydrobenzo[d]isoxazol-3-ol (28d), which quite surprisingly turned out to be more potent than GABA at both GAT1 and GAT2 subtypes. The GAT1 activity was shown to reside in (R)-28d whereas (R)-28d and (S)-28d contributed equally to GAT2 activity. This makes (S)-28d a GAT2 selective compound, and (R)-28d equally effective in inhibition of GAT1 and GAT2 mediated GABA transport. All compounds tested were effective as anticonvulsant reflecting that these compounds have blood-brain barrier permeating ability. (C) 2004 Elsevier Ltd. All rights reserved.
  • Selective mGAT2 (BGT-1) GABA Uptake Inhibitors: Design, Synthesis, and Pharmacological Characterization
    作者:Stine B. Vogensen、Lars Jørgensen、Karsten K. Madsen、Nrupa Borkar、Petrine Wellendorph、Jonas Skovgaard-Petersen、Arne Schousboe、H. Steve White、Povl Krogsgaard-Larsen、Rasmus P. Clausen
    DOI:10.1021/jm301872x
    日期:2013.3.14
    beta-Amino acids sharing a lipophilic diaromatic side chain were synthesized and characterized pharmacologically on mouse GABA transporter subtypes mGAT1-4. The parent amino acids were also characterized. Compounds 13a, 13b, and 17b displayed more than 6-fold selectivity for mGAT2 over mGAT1. Compound 17b displayed anticonvulsive properties inferring a role of mGAT2 in epileptic disorders. These results provide new neuropharmacological tools and a strategy for designing subtype selective GABA transport inhibitors.
  • Iridium-Catalyzed Enantioselective Hydrogenation of Unsaturated Heterocyclic Acids
    作者:Song Song、Shou-Fei Zhu、Liu-Yang Pu、Qi-Lin Zhou
    DOI:10.1002/anie.201301341
    日期:2013.6.3
    binding: A highly enantioselective hydrogenation of unsaturated heterocyclic acids has been developed by using chiral iridium/spirophosphino oxazoline catalysts (see scheme; BArF−=tetrakis[3,5‐bis(trifluoromethyl)phenyl]borate, Boc=tert‐butoxycarbonyl). This reaction provided an efficient method for the preparation of optically active heterocyclic acids with excellent enantioselectivities.
    螺旋结合:一种高度对映选择性的不饱和杂环羧酸的加氢已经通过使用手性铱/ spirophosphino恶唑啉催化剂开发(参见方案; BAR ˚F - =四[3,5-双(三氟甲基)苯基]硼酸盐,的Boc =叔丁氧羰基) 。该反应提供了制备具有优异对映选择性的旋光杂环酸的有效方法。
查看更多